Identification of a novel human rhinovirus C type by antibody capture VIDISCA-454

Seyed Mohammad Jazaeri Farsani; Bas B.Oude Munnink; Marta Canuti; Martin Deijs; Matthew Cotten; Maarten F. Jebbink; Joost Verhoeven; Paul Kellam; Katherine Loens; Herman Goossens; Margareta Ieven; Lia van der Hoek

doi:10.3390/v7010239

Identification of a novel human rhinovirus C type by antibody capture VIDISCA-454

Seyed Mohammad Jazaeri Farsani
, Bas B.Oude Munnink
, Marta Canuti
, Martin Deijs
, Matthew Cotten
, Maarten F. Jebbink
, Joost Verhoeven
, Paul Kellam
, Katherine Loens
, Herman Goossens
, Margareta Ieven
, Lia van der Hoek^*

^*Corresponding author for this work

Amsterdam UMC
Tehran University of Medical Sciences
Academisch Medisch Centrum (A'dam)
Memorial University of Newfoundland
Wellcome Sanger Institute
Antwerp University Hospital

Research output: Contribution to journal › Article › Academic › peer-review

3 Citations (Scopus)

Abstract

Causative agents for more than 30 percent of respiratory infections remain unidentified, suggesting that unknown respiratory pathogens might be involved. In this study, antibody capture VIDISCA-454 (virus discovery cDNA-AFLP combined with Roche 454 high-throughput sequencing) resulted in the discovery of a novel type of rhinovirus C (RV-C). The virus has an RNA genome of at least 7054 nt and carries the characteristics of rhinovirus C species. The gene encoding viral protein 1, which is used for typing, has only 81% nucleotide sequence identity with the closest known RV-C type, and, therefore, the virus represents the first member of a novel type, named RV-C54.

Original language	English
Pages (from-to)	239-251
Number of pages	13
Journal	Viruses
Volume	7
Issue number	1
DOIs	https://doi.org/10.3390/v7010239
Publication status	Published - 19 Jan 2015
Externally published	Yes

Bibliographical note

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.3390/v7010239Licence: CC BY

viruses-07-00239Final published version, 1.85 MBLicence: CC BY

Cite this

@article{3e219f6286124fc4a67ecd1375c98e6a,

title = "Identification of a novel human rhinovirus C type by antibody capture VIDISCA-454",

abstract = "Causative agents for more than 30 percent of respiratory infections remain unidentified, suggesting that unknown respiratory pathogens might be involved. In this study, antibody capture VIDISCA-454 (virus discovery cDNA-AFLP combined with Roche 454 high-throughput sequencing) resulted in the discovery of a novel type of rhinovirus C (RV-C). The virus has an RNA genome of at least 7054 nt and carries the characteristics of rhinovirus C species. The gene encoding viral protein 1, which is used for typing, has only 81\% nucleotide sequence identity with the closest known RV-C type, and, therefore, the virus represents the first member of a novel type, named RV-C54.",

author = "Farsani, \{Seyed Mohammad Jazaeri\} and Munnink, \{Bas B.Oude\} and Marta Canuti and Martin Deijs and Matthew Cotten and Jebbink, \{Maarten F.\} and Joost Verhoeven and Paul Kellam and Katherine Loens and Herman Goossens and Margareta Ieven and \{van der Hoek\}, Lia",

note = "{\textcopyright} 2015 by the authors; licensee MDPI, Basel, Switzerland.",

year = "2015",

month = jan,

day = "19",

doi = "10.3390/v7010239",

language = "English",

volume = "7",

pages = "239--251",

journal = "Viruses",

issn = "1999-4915",

publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",

number = "1",

}

TY - JOUR

T1 - Identification of a novel human rhinovirus C type by antibody capture VIDISCA-454

AU - Farsani, Seyed Mohammad Jazaeri

AU - Munnink, Bas B.Oude

AU - Canuti, Marta

AU - Deijs, Martin

AU - Cotten, Matthew

AU - Jebbink, Maarten F.

AU - Verhoeven, Joost

AU - Kellam, Paul

AU - Loens, Katherine

AU - Goossens, Herman

AU - Ieven, Margareta

AU - van der Hoek, Lia

PY - 2015/1/19

Y1 - 2015/1/19

N2 - Causative agents for more than 30 percent of respiratory infections remain unidentified, suggesting that unknown respiratory pathogens might be involved. In this study, antibody capture VIDISCA-454 (virus discovery cDNA-AFLP combined with Roche 454 high-throughput sequencing) resulted in the discovery of a novel type of rhinovirus C (RV-C). The virus has an RNA genome of at least 7054 nt and carries the characteristics of rhinovirus C species. The gene encoding viral protein 1, which is used for typing, has only 81% nucleotide sequence identity with the closest known RV-C type, and, therefore, the virus represents the first member of a novel type, named RV-C54.

AB - Causative agents for more than 30 percent of respiratory infections remain unidentified, suggesting that unknown respiratory pathogens might be involved. In this study, antibody capture VIDISCA-454 (virus discovery cDNA-AFLP combined with Roche 454 high-throughput sequencing) resulted in the discovery of a novel type of rhinovirus C (RV-C). The virus has an RNA genome of at least 7054 nt and carries the characteristics of rhinovirus C species. The gene encoding viral protein 1, which is used for typing, has only 81% nucleotide sequence identity with the closest known RV-C type, and, therefore, the virus represents the first member of a novel type, named RV-C54.

UR - https://www.scopus.com/pages/publications/84921696506

U2 - 10.3390/v7010239

DO - 10.3390/v7010239

M3 - Article

C2 - 25606972

AN - SCOPUS:84921696506

SN - 1999-4915

VL - 7

SP - 239

EP - 251

JO - Viruses

JF - Viruses

IS - 1

ER -

Identification of a novel human rhinovirus C type by antibody capture VIDISCA-454

Abstract

Bibliographical note

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this